To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Collagen/thrombin and autologous platelet hemostatic agent reduces transfusion during TKA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
May 2013

Collagen/thrombin and autologous platelet hemostatic agent reduces transfusion during TKA

Vol: 2| Issue: 4| Number:16| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Prospective randomized evaluation of a collagen/thrombin and autologous platelet hemostatic agent during total knee arthroplasty

J Arthroplasty. 2012 May;27(5):695-702. Epub 2011 Oct 27

Contributing Authors:
MR Bloomfield AK Klika RM Molloy MI Froimson VE Krebs WK Barsoum

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

100 patients undergoing primary total knee arthroplasty were randomised to receive either standard haemostasis and Vitagel, a haemostatic treatment, or a control group receiving standard haemostasis alone to examine the effects on blood transfusions. No patients in the Vitagel group required blood transfusions compared with 10% of the patients in the control group. Patients in the Vitagel group al...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue